US, WASHINGTON (ORDO NEWS) — U.S. authorities have officially authorized the use of remdesivir, used in the fight against Ebola, to treat patients with severe coronavirus. Japan is preparing to approve the drug.
The US Department of Health’s Food and Drug Administration (FDA) has approved the use of the antiviral drug remdesivir in the treatment of patients with coronavirus. This is stated in a statement on the organization’s website. The same remedy was used to combat Ebola.
The FDA has approved the use of remdesivir for patients with severe illness. The statement emphasizes that there is not so much data on the safety and effectiveness of this drug, however, during the tests, the drug shortened the recovery period of infected people.
The drug was created by the American pharmaceutical company Gilead Sciences. This week, she reported on the positive results of a clinical study of remdesivir in the fight against coronavirus.
They also decided to approve the use of remdesivir for the treatment of patients with coronavirus in Japan, reports NHK. According to the television company, they can finally approve the use of the drug in about a week. When this happens, remdesivir will be the first drug approved to treat patients with coronavirus in this country.
In late March, the Russian Ministry of Health included remdesivir in the list of drugs undergoing clinical trials. Umifenovir and favipiravir were also included.
Contact us: email@example.com